This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial.
Journal of psychopharmacology (Oxford, England), 2698811251362390
Citation
McGowan, Niall M; Rucker, James J; Yehuda, Rachel; Agrawal, Manish; Modlin, Nadav Liam; Simmons, Hollie; Tofil-Kaluza, Agata; Das, Shriya; Goodwin, Guy M. (2025). Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial.. Journal of psychopharmacology (Oxford, England), 2698811251362390. https://doi.org/10.1177/02698811251362390